MassBiologics developing promising alternative treatment for diphtheria in wake of global antitoxin shortage

MassBiologics developing promising alternative treatment for diphtheria in wake of global antitoxin shortage

A worsening shortage of the antitoxin used to treat diphtheria, the deaths of two unvaccinated children to the disease in Europe and declining vaccination rates demonstrate the need for a new approach, and MassBiologics of UMass Medical School is developing one, according to a Jan. 13 story in the journal Science.

Read more

Research at a Glance

Faculty


The Research Enterprise 

  • FY 2016 Grant Funding: $281 M
  • FY 2016 NIH Funding: $148 M
  • 1152 externally sponsored projects
  • 400 Postdoctoral Scholars
  • 440 Graduate Students
  • $33M in licensing revenue in 2014-15

Participate in Clinical Research

Research Centers and Institutes

 


Support Research@UMMS

Take Action Make a Gift Today - UMass Medical School


Events
Publications
Find an Investigator

▴ Back To Top
Section Menu To Top
Office of research CCTS research @ umms